Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ALECENSA safely and effectively. See full prescribing information for ALECENSA. ALECENSA® (alectinib) capsules, for oral use Initial U.S. Approval: 2015
Medication labelWhy this: Advisory · dailymed-prescription
ALECENSA is indicated as adjuvant treatment in adult patients following tumor resection of anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) (tumors ≥ 4 cm or node positive), as detected by an FDA-approved test [see Dosage & Administration (2.1)]. ALECENSA is indicated for the treatment of adult patients with ALK-positive metastatic NSCLC as detected by an FDA-approved test [see Dosage & Administration (2.1)].
- generic_name
- alectinib hydrochloride
- product_names
- ALECTINIB HYDROCHLORIDE
- ndc
- 50242-130, 50242-130-01, 50242-130-86
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en